RAPID Foundation (Research Alliance for Primary Immunodeficiency Discoveries) Revenue

Research Services • • 1-10 Employees

RAPID Foundation (Research Alliance for Primary Immunodeficiency Discoveries) revenue & valuation

Annual revenue	$85,555
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Research Services industry and current estimated revenues	$273,776
Total funding	No funding

Key Contact at RAPID Foundation (Research Alliance for Primary Immunodeficiency Discoveries)

Frank Dionisi

Founder

Company overview

Headquarters	XX
Website	rapidfoundation.org
NAICS	5417
Founded	2025
Employees	1-10

About RAPID Foundation (Research Alliance for Primary Immunodeficiency Discoveries)

Research Alliance for Primary Immunodeficiency Discoveries (RAPID) pioneers research in gene therapy and innovative treatments for Primary Immunodeficiency Disorders. We fund genetic testing and mitochondrial health initiatives, while expanding education and awareness to transform care for affected children and families. Our mission: to accelerate breakthroughs and improve lives impacted by rare genetic diseases through research, support, and advocacy.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

RAPID Foundation (Research Alliance for Primary Immunodeficiency Discoveries) has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

RAPID Foundation (Research Alliance for Primary Immunodeficiency Discoveries) has never raised funding before.

Frequently asked questions

RAPID Foundation (Research Alliance for Primary Immunodeficiency Discoveries) is located in XX.

RAPID Foundation (Research Alliance for Primary Immunodeficiency Discoveries) generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.

RAPID Foundation (Research Alliance for Primary Immunodeficiency Discoveries) has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

RAPID Foundation (Research Alliance for Primary Immunodeficiency Discoveries) was founded in 2025, making it 1 years old. The company has established itself as a significant player in its industry over this time.

RAPID Foundation (Research Alliance for Primary Immunodeficiency Discoveries) has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at RAPID Foundation (Research Alliance for Primary Immunodeficiency Discoveries)

Frank Dionisi

Founder

4.8

40,000 users